Clinical Trial Update: A Phase 2 to Evaluate the Efficacy, Safety and Tolerability of Combinations of Bedaquiline, Moxifloxacin, PA-824 and Pyrazinamide in Adult Subjects With Drug-Sensitive or Multi Drug-Resistant Pulmonary Tuberculosis. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating combinations of bedaquiline, moxifloxacin, PA-824 and pyrazinamide for drug-sensitive and multi-drug resistant pulmonary tuberculosis; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• Moxifloxacin (moxifloxacin)
• PA-824 (pretomanid)
• Pyrazinamide (pyrazinamide)
• bedaquiline (bedaquiline)

Snippet

Sponsor: Global Alliance for TB Drug Development | Conditions: Tuberculosis | Phase 2 | Status: COMPLETED | Results posted: 2019-07-26